DISA (532) AI Stock Analysis

• Market Cap: S$14.09M
• Dividend Yield: N/A
• Average Volume (3M): N/A
• Price to Earnings (P/E): ―
• Beta (1Y): -0.31
• Revenue Growth: -19.20%
• EPS Growth: N/A
• Country: SG
• Employees: 13
• Sector: Technology
• Sector Strength: 88
• Industry: Software - Application
• EPS (TTM): 0.00
• Shares Outstanding: 14,089,804,000
• 10 Day Avg. Volume: N/A
• 30 Day Avg. Volume: N/A
• PEG Ratio: 0.00
• Price to Book (P/B): 4.52
• Price to Sales (P/S): 1.75
• P/FCF Ratio: -5.24
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 37 Underperform
• Price Target: <S$0.01 ▼(-50.00% Downside)

The overall stock score is heavily impacted by significant financial challenges, including declining revenues and persistent losses. The lack of technical and valuation data further limits the ability to assess the stock's potential, resulting in a low score.

Positive Factors

Business Model Diversification

A diversified business model with multiple revenue streams, including stable government contracts, enhances resilience and reduces dependency on a single market.

Low Debt Levels

Low debt levels provide financial flexibility and reduce interest burden, allowing the company to navigate financial challenges more effectively.

R&D Focus

Strong R&D focus fosters innovation, leading to proprietary technologies that can drive future growth and competitive advantage.

Negative Factors

Declining Revenues

Consistent revenue decline indicates potential loss of market share and challenges in sustaining growth, impacting long-term viability.

Negative Profitability

Sustained negative profitability undermines financial health, limiting reinvestment capacity and shareholder returns.

Cash Flow Challenges

Negative cash flows highlight liquidity issues, constraining operational flexibility and investment in growth opportunities.

DISA Business Overview & Revenue Model

Company Description

DISA Limited, an investment holding company, engages in technology business in Singapore, the People's Republic of China, Hong Kong, and the United States. The company offers Point-of-Sale Activation Smart Lock, a digital asset protection solution that makes consumer electronic products non-functional until the point of payment; single-scan serilization smart barcode to prevent return fraud; FreshCounts, which provides item tracking capabilities; DiSa Smart Shelf and DiSa Smart Case to deter rob-and-run crimes; and Product ID Live, a smart asset protection tool that combats shrink and eliminates return fraud. Its asset protection solutions are deployed on consumer products sold at retail stores to protect retailers and their suppliers from theft and return fraud. The company also provides digital security, anti-theft, and anti-counterfeiting solutions; and marketing and technical support services. In addition, it engages in the research and development business; sell of semiconductor devices; and manufacturing and distribution of healthcare tools. The company was formerly known as Equation Summit Limited and changed its name to DISA Limited in February 2017. DISA Limited was incorporated in 1975 and is based in Singapore.

How the Company Makes Money

DISA generates revenue through multiple streams, including government contracts for defense and technology services, software licensing and maintenance fees, and consulting services for system integration. The company also benefits from long-term partnerships with key government agencies, which provide a stable source of income through awarded contracts. Additionally, DISA's focus on research and development allows it to create proprietary technologies that can be licensed or sold, further contributing to its financial performance.

DISA Financial Statement Overview

Summary

DISA faces significant financial challenges with declining revenues, persistent losses, and cash flow difficulties. Despite a low debt level, negative profitability metrics and cash flow issues pose substantial risks.

Income Statement

DISA's income statement reveals significant challenges. The company has experienced declining revenues over the past years, with a notable decrease of 14.17% in the most recent year. Margins are under pressure, with negative net profit and EBIT margins indicating ongoing losses. Despite a slight improvement in gross profit margin, the overall profitability remains weak.

Balance Sheet

The balance sheet shows a relatively low debt-to-equity ratio, suggesting manageable leverage. However, the return on equity is negative, reflecting the company's inability to generate profits from shareholders' equity. The equity ratio is moderate, indicating a balanced capital structure, but the persistent losses are a concern.

Cash Flow

Cash flow analysis indicates negative operating and free cash flows, although there is a slight improvement in free cash flow growth. The operating cash flow to net income ratio is negative, highlighting cash flow challenges. The free cash flow to net income ratio is slightly above 1, suggesting some alignment between cash flow and accounting profits.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	6.10M	6.09M	7.54M	10.92M	24.27M	19.53M
Gross Profit	651.00K	701.00K	723.00K	742.00K	1.53M	1.30M
EBITDA	-2.81M	-2.69M	-1.77M	-2.15M	-1.64M	-3.12M
Net Income	-2.55M	-2.54M	-1.92M	-2.46M	-2.00M	-3.17M
Balance Sheet
Total Assets	3.33M	3.33M	2.73M	3.48M	5.60M	7.76M
Cash, Cash Equivalents and Short-Term Investments	2.71M	2.71M	1.39M	1.67M	3.05M	5.11M
Total Debt	115.00K	115.00K	497.00K	414.00K	252.00K	562.00K
Total Liabilities	976.00K	976.00K	1.25M	1.21M	1.02M	1.50M
Stockholders Equity	2.36M	2.36M	1.35M	2.27M	4.58M	6.25M
Cash Flow
Free Cash Flow	-1.92M	-2.04M	-1.02M	-1.11M	-952.00K	-586.00K
Operating Cash Flow	-1.91M	-2.03M	-1.01M	-1.11M	-728.00K	-504.00K
Investing Cash Flow	122.00K	122.00K	863.00K	28.00K	-1.07M	60.00K
Financing Cash Flow	3.15M	3.15M	-123.00K	-223.00K	-185.00K	1.95M

DISA Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BBW	69 Neutral	S$360.00M	12.71	70.97%	5.52%	32.76%	54.96%
Sector *	61 Neutral	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
FQ7	39 Underperform	S$72.89M	―	-28.19%	―	―	―
532	37 Underperform	S$14.09M	―	-137.13%	―	-19.20%	―

DISA Corporate Events

DISA Limited Conducts Annual General Meeting with Key Resolutions

DISA Limited held its Annual General Meeting (AGM) on October 24, 2025, in Singapore, where key company figures, including the Executive Chairman, Managing Director, and CEO, Mr. Chng Weng Wah, were present. The meeting proceeded with the confirmation of a quorum, and shareholders were informed of their rights to ask questions and vote on resolutions by poll, as per the regulations of the Singapore Exchange Securities Trading Limited (SGX-ST).

DISA Limited Conducts EGM with Key Voting Procedures

DISA Limited, a company incorporated in Singapore, held an Extraordinary General Meeting (EGM) on October 24, 2025, at its premises in Bukit Merah Central, Singapore. The meeting was chaired by Mr. Chng Weng Wah, the Executive Chairman, Managing Director, and CEO of the company. During the EGM, the shareholders were informed about the voting process for the resolution, which would be conducted by poll in accordance with the Catalist Rules of the SGX-ST. The Chairman also mentioned that some shareholders had appointed him as their proxy for the voting process.

DISA Limited Expands Healthcare Reach with New AVAT Device Trial

DISA Limited’s subsidiary, Digital Life Line, has initiated a clinical trial for its Automated Visual Acuity Test (AVAT) device at Ng Teng Fong General Hospital. This trial aims to demonstrate the device’s effectiveness in a high-volume community hospital, potentially expanding its market beyond tertiary specialist centers. The AVAT device, which allows patients to self-administer eye exams, has already shown success at Singapore’s National University Hospital by improving workflow efficiency and reducing patient wait times. This strategic move is expected to create a new revenue stream and address the growing demand for ophthalmological services in mainstream healthcare settings.